Business news

    Cann Group (ASX:CAN) announces a board change

    Article Image

    Cann Group (ASX:CAN) has just announced a change to its board.

    Cann Group announced today that Mr Robert Barnes and Dr Julian Chick will be appointed to the Board of Director to fill casual vacancies. Mr Barnes' appointment will take effect immediately. Dr Chick's appointment will take effect on 26 October 2022.

    Mr Barnes is an experienced senior executive who has delivered extensive leadership and operational outcomes across a wide variety of healthcare industries, including pharmaceutical, nutraceutical, infant formula, consumer, medical devices, and diagnostics.

    He has an applied science degree in Medical Science, a MBA, and is a Graduate of the Australian Institute of Company Directors.

    Dr Chick has over 25 years of experience in the biotechnology and medical technology sectors, as well as in investment banking.

    He has worked with both public and private companies, bringing a number of technologies through from discovery to markets, as well as experience in capital raisings, company restructuring, licensing, business development and M&A transactions.

    Shares of Cann Group have stable following the announcement.

    Any change in the make-up of a company?s board can have an impact on a company?s stock price.

    Generally, age-related turnovers and voluntary resignations have a marginal impact on the share price.

    However, when either the Chairman or another board member is ousted, this can have a significant impact on the stock price.

    As the role of the board is to endorse the strategy of the business, changes to the board can have an impact on the strategic direction of the company and therefore it?s future profitability.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa